GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (TSX:CSCI) » Definitions » PB Ratio

Cosciens Biopharma (TSX:CSCI) PB Ratio : 0.45 (As of Mar. 04, 2025)


View and export this data going back to 1992. Start your Free Trial

What is Cosciens Biopharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-04), Cosciens Biopharma's share price is C$3.95. Cosciens Biopharma's Book Value per Share for the quarter that ended in Sep. 2024 was C$8.68. Hence, Cosciens Biopharma's PB Ratio of today is 0.45.

Good Sign:

Cosciens Biopharma Inc stock PB Ratio (=0.47) is close to 10-year low of 0.43

The historical rank and industry rank for Cosciens Biopharma's PB Ratio or its related term are showing as below:

TSX:CSCI' s PB Ratio Range Over the Past 10 Years
Min: 0.43   Med: 1.72   Max: 17.74
Current: 0.47

During the past 13 years, Cosciens Biopharma's highest PB Ratio was 17.74. The lowest was 0.43. And the median was 1.72.

TSX:CSCI's PB Ratio is ranked better than
91.05% of 1285 companies
in the Biotechnology industry
Industry Median: 2.34 vs TSX:CSCI: 0.47

During the past 12 months, Cosciens Biopharma's average Book Value Per Share Growth Rate was -46.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 6.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 38.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cosciens Biopharma was 708.10% per year. The lowest was -10.90% per year. And the median was 23.00% per year.

Back to Basics: PB Ratio


Cosciens Biopharma PB Ratio Historical Data

The historical data trend for Cosciens Biopharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma PB Ratio Chart

Cosciens Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 2.10 1.70 1.43 0.53

Cosciens Biopharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.53 0.71 0.52 0.58

Competitive Comparison of Cosciens Biopharma's PB Ratio

For the Biotechnology subindustry, Cosciens Biopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosciens Biopharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's PB Ratio falls into.



Cosciens Biopharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cosciens Biopharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=3.95/8.684
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Cosciens Biopharma  (TSX:CSCI) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Cosciens Biopharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosciens Biopharma Business Description

Traded in Other Exchanges
Address
c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, Toronto, ON, CAN, M5K 1E7
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
Executives
Dennis Turpin Director
Gilles Gagnon Director